Page last updated: 2024-09-03
cimadronate and Osteogenic Sarcoma
cimadronate has been researched along with Osteogenic Sarcoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fushiki, S; Horie, N; Kimura, S; Kubo, T; Maekawa, T; Matsui, T; Murata, H; Nishigaki, Y; Nogawa, M; Segawa, H; Yuasa, T | 1 |
Other Studies
1 other study(ies) available for cimadronate and Osteogenic Sarcoma
Article | Year |
---|---|
The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosis.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Diphosphonates; Disease Models, Animal; Drug Screening Assays, Antitumor; GTP-Binding Proteins; Imidazoles; Mice; Osteosarcoma | 2006 |